Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a Cash Flow Reinvestment Rate of 0.26x as of September 2025, reinvesting CN¥22.77 Million (capex CN¥22.77 Million ) from operating cash flow of CN¥88.11 Million. Explore 300357 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
Cash flow reinvestment rate of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. Historical reinvestment intensity for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd across 16 annual periods. Explore 300357 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2009–2024)
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2009 to 2024. Year-by-year capital reinvestment analysis for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.26x | CN¥593.90 Million | CN¥262.44 Million | CN¥117.97 Million | ▲ +119.1% |
| 2023 | 1.03x | CN¥401.03 Million | CN¥388.32 Million | CN¥209.16 Million | ▲ +74.4% |
| 2022 | 0.59x | CN¥213.34 Million | CN¥360.28 Million | CN¥188.74 Million | ▼ -7.7% |
| 2021 | 0.64x | CN¥231.21 Million | CN¥360.58 Million | CN¥122.16 Million | ▲ +69.1% |
| 2020 | 0.38x | CN¥97.16 Million | CN¥256.22 Million | CN¥70.16 Million | ▼ -85.8% |
| 2019 | 2.67x | CN¥620.83 Million | CN¥232.93 Million | CN¥99.83 Million | ▲ +127.6% |
| 2018 | 1.17x | CN¥241.75 Million | CN¥206.45 Million | CN¥57.75 Million | ▲ +5.4% |
| 2017 | 1.11x | CN¥176.73 Million | CN¥159.13 Million | CN¥34.73 Million | ▼ -1.6% |
| 2016 | 1.13x | CN¥138.50 Million | CN¥122.77 Million | CN¥35.93 Million | ▲ +85.1% |
| 2015 | 0.61x | CN¥69.97 Million | CN¥114.82 Million | CN¥31.51 Million | ▲ +125.0% |
| 2014 | 0.27x | CN¥22.67 Million | CN¥83.70 Million | CN¥22.67 Million | ▼ -9.9% |
| 2013 | 0.30x | CN¥17.53 Million | CN¥58.30 Million | CN¥17.53 Million | ▲ +70.8% |
| 2012 | 0.18x | CN¥7.25 Million | CN¥41.17 Million | CN¥7.25 Million | ▼ -15.6% |
| 2011 | 0.21x | CN¥3.99 Million | CN¥19.15 Million | CN¥3.99 Million | ▼ -71.3% |
| 2010 | 0.73x | CN¥10.56 Million | CN¥14.54 Million | CN¥10.56 Million | ▼ -57.3% |
| 2009 | 1.70x | CN¥21.48 Million | CN¥12.63 Million | CN¥21.48 Million | — |